David Hibbert Watson sold $70k of AGX
PRESIDENT AND CEO at ARGAN INC. 500 shares at an average of $139.89, traded Dec 23, 2024, filed Apr 21, 2025.
Score components
- +25RoleCEO
- +8Trade size$70k at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-011085, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 23, 2024 | SOpen-market sale Common Stockindirect: Held in The David and Laura Watson Foundation | -500 | $139.89 | $70k | 0 | Apr 21, 2025 |
| Apr 16, 2025 | MOption exercise Common Stock | +1,856 | $0.00 | $0 | 52,647 | Apr 21, 2025 |
| Apr 17, 2025 | MOption exercise Common Stock | +2,286 | $0.00 | $0 | 54,933 | Apr 21, 2025 |
| Apr 18, 2025 | MOption exercise Common Stock | +1,958 | $0.00 | $0 | 56,891 | Apr 21, 2025 |
| Apr 18, 2025 | MOption exercise Common Stock | +11,745 | $0.00 | $0 | 68,636 | Apr 21, 2025 |
| Apr 16, 2025 | MOption exercise Time-Based Restricted Stock Unitsderivative | -3,333 | $0.00 | $0 | 18,001 | Apr 21, 2025 |
| Apr 16, 2025 | AGrant or award Time-Based Restricted Stock Unitsderivative | +4,000 | $0.00 | $0 | 22,001 | Apr 21, 2025 |
| Apr 16, 2025 | AGrant or award Option to Purchase Common Stockderivative | +2,000 | $0.00 | $0 | 13,334 | Apr 21, 2025 |
| Apr 16, 2025 | AGrant or award Performance-Based Restricted Stock Unitsderivative | +3,000 | $0.00 | $0 | 22,000 | Apr 21, 2025 |
| Apr 16, 2025 | AGrant or award Earnings Per Share Performance-Based Restricted Stock Unitsderivative | +7,500 | $0.00 | $0 | 25,500 | Apr 21, 2025 |
| Apr 17, 2025 | MOption exercise Time-Based Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 18,001 | Apr 21, 2025 |
| Apr 18, 2025 | MOption exercise Time-Based Restricted Stock Unitsderivative | -3,334 | $0.00 | $0 | 14,667 | Apr 21, 2025 |
| Apr 18, 2025 | MOption exercise Performance-Based Restricted Stock Unitsderivative | -10,000 | $0.00 | $0 | 12,000 | Apr 21, 2025 |
Related signals
Other insiders at ARGAN INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | ARGAN INC | Charles Edwin Collins IV CHIEF EXECUTIVE OFFICER, GEMMA | $1.3M 5,000 shares | -19% | |
| 43Moderate | ARGAN INC | Peter W Getsinger director | $265k 1,000 shares | -8% | |
| 75Notable | ARGAN INC | James W Quinn director | $4.3M 16,557 shares | -100% | |
| 60Notable | ARGAN INC | Charles Edwin Collins IV CHIEF EXECUTIVE OFFICER, GEMMA | $1.9M 7,500 shares | -26% | |
| 45Moderate | ARGAN INC | Karen Sweeney director | $103k 390 shares | -23% | |
| 40Moderate | ARGAN INC | Peter W Getsinger director | $625k 2,609 shares | -17% | |
| 75Notable | ARGAN INC | Charles Edwin Collins IV CHIEF EXECUTIVE OFFICER, GEMMA | $1.6M 6,500 shares | -31% | |
| 55Moderate | ARGAN INC | John Ronald Jeffrey Jr. director | $618k 2,621 shares | -22% | |
| 43Moderate | ARGAN INC | Richard H Deily Compliance Officer, Former CFO | $389k 1,604 shares | -17% | |
| 67Notable | ARGAN INC | Cynthia Flanders director | $469k 2,000 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.